Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (101-110 of 311) with videos related to

Pageof 32
Sort By:
Respiratory Medicine|June 15, 2017
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension studyMichael Halank, Marius M Hoeper, Hossein-Ardeschir Ghofrani, et al.
Open Forum Infectious Diseases|October 30, 2019
Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza EpidemicKlaus Stahl, Benjamin Seeliger, Markus Busch, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 22, 2008
Interventional lung assist: a new concept of protective ventilation in bridge to lung transplantationStefan Fischer, Marius M Hoeper, Thomas Bein, et al.
Respiratory Medicine|December 12, 2024
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studiesMarius M Hoeper, Stephan Rosenkranz, David B Badesch, et al.
European Heart Journal|July 6, 2010
Circulating angiopoietins in idiopathic pulmonary arterial hypertensionPhilipp Kümpers, Nils Nickel, Alexander Lukasz, et al.
International Journal of Cardiology|September 30, 2018
Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018Hanno H Leuchte, Henrik Ten Freyhaus, Henning Gall, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 18, 2014
Performance of perfusion-weighted Fourier decomposition MRI for detection of chronic pulmonary emboliChristian Schönfeld, Serghei Cebotari, Andreas Voskrebenzev, et al.
International Journal of Cardiology|February 15, 2014
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patientsGérald Simonneau, Nazzareno Galiè, Pavel Jansa, et al.
Journal of Intensive Care Medicine|October 16, 2020
Effect of Therapeutic Plasma Exchange on Immunoglobulin Deficiency in Early and Severe Septic ShockKlaus Stahl, Rolf Bikker, Benjamin Seeliger, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated evidence-based treatment algorithm in pulmonary arterial hypertensionRobyn J Barst, J Simon R Gibbs, Hossein A Ghofrani, et al.
Pageof 32

Showing results (101-110 of 311) with videos related to

Sort By:
Pageof 32
Respiratory Medicine|June 15, 2017
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension studyMichael Halank, Marius M Hoeper, Hossein-Ardeschir Ghofrani, et al.
Open Forum Infectious Diseases|October 30, 2019
Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza EpidemicKlaus Stahl, Benjamin Seeliger, Markus Busch, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 22, 2008
Interventional lung assist: a new concept of protective ventilation in bridge to lung transplantationStefan Fischer, Marius M Hoeper, Thomas Bein, et al.
Respiratory Medicine|December 12, 2024
Riociguat in pulmonary arterial hypertension: Application of the 4-strata COMPERA 2.0 risk assessment tool in the PATENT studiesMarius M Hoeper, Stephan Rosenkranz, David B Badesch, et al.
European Heart Journal|July 6, 2010
Circulating angiopoietins in idiopathic pulmonary arterial hypertensionPhilipp Kümpers, Nils Nickel, Alexander Lukasz, et al.
International Journal of Cardiology|September 30, 2018
Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018Hanno H Leuchte, Henrik Ten Freyhaus, Henning Gall, et al.
Journal of Magnetic Resonance Imaging : JMRI|September 18, 2014
Performance of perfusion-weighted Fourier decomposition MRI for detection of chronic pulmonary emboliChristian Schönfeld, Serghei Cebotari, Andreas Voskrebenzev, et al.
International Journal of Cardiology|February 15, 2014
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patientsGérald Simonneau, Nazzareno Galiè, Pavel Jansa, et al.
Journal of Intensive Care Medicine|October 16, 2020
Effect of Therapeutic Plasma Exchange on Immunoglobulin Deficiency in Early and Severe Septic ShockKlaus Stahl, Rolf Bikker, Benjamin Seeliger, et al.
Journal of the American College of Cardiology|June 27, 2009
Updated evidence-based treatment algorithm in pulmonary arterial hypertensionRobyn J Barst, J Simon R Gibbs, Hossein A Ghofrani, et al.
Pageof 32